First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

PurposeThe benefit of using the Zilver PTX drug-eluting stent (DES) in superficial femoral artery (SFA) lesions has been demonstrated in multiple clinical studies. This prospective, multicenter study evaluated the 1-year safety and effectiveness of the DES for the treatment of femoropopliteal lesion...

Full description

Bibliographic Details
Main Authors: Wei Ye, Tanja Böhme, Weiguo Fu, Changwei Liu, Xiaoming Zhang, Peng Liu, Jiwei Zhang, Yinghua Zou, Xinwu Lu, Aaron E. Lottes, Erin E. O'Leary, Thomas Zeller, Michael D. Dake
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
drug-eluting stent
paclitaxel-eluting stent
peripheral artery disease
peripheral vascular disease
superficial femoral artery
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.877578/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.877578/full

Similar Items